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Clark electrodeMethadone is a widely used therapeutic opioid in narcotic addiction and neuropathic pain syndromes.
Oncologists regularly use methadone as a long-lasting analgesic. Recently it has also been proposed as a
promising agent in leukemia therapy, especially when conventional therapies are not effective. Nevertheless,
numerous reports indicate a negative impact on human cognition with chronic exposure to opiates. Thus,
clariﬁcation of methadone toxicity is required. In SH-SY5Y cells we found that high concentrations of
methadone were required to induce cell death. Methadone-induced cell death seems to be related to necrotic
processes rather than typical apoptosis. Cell cultures challenged with methadone presented alterations in
mitochondrial outer membrane permeability. A mechanism that involves Bax translocation to the
mitochondria was observed, accompanied with cytochrome c release. Furthermore, no participation of
known protein regulators of apoptosis such as Bcl-XL and p53 was observed. Interestingly, methadone-
induced cell death took place by a caspases-independent pathway; perhaps due to its ability to induce a
drastic depletion in cellular ATP levels. Therefore, we studied the effect of methadone on isolated rat liver
mitochondria. We observed that methadone caused mitochondrial uncoupling, coinciding with the
ionophoric properties of methadone, but did not cause swelling of the organelles. Overall, the effects
observed for cells in the presence of supratherapeutic doses of methadone may result from a “bioenergetic
crisis.” A decreased level of cellular energy may predispose cells to necrotic-like cell death.ía, Departamento de Ciencias
a Mancha, Avda Almansa 14,
967599327.
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.The therapeutic opioid methadone (D,L-methadone hydrochlo-
ride) is frequently used in different therapies including opioid
addiction [1], long-lasting analgesics in cancer and neuropathic pain
syndromes [1–3]. Because methadone kills sensitive leukemia cells
and breaks chemoresistance and apoptosis resistance in leukemias,
it has been proposed as a promising agent in leukemia therapy,
especially when conventional therapies are not effective [4].
However, numerous reports indicate a negative impact of chronic
exposure to opioid drugs on human cognition. Heroin addicts display
a reduction in performance on memory tasks [5,6], correlating with
abuse severity [7]. Moreover, patients continuously taking, moderatedoses of opioids for chronic pain, and former heroin addicts subjected
to methadone maintenance programs also have been reported to
show impaired cognitive abilities in psychomotor performance,
information processing, attention, problem solving, memory, deci-
sion making, and reaction time [7–17]. Thus, research on the toxicity
of methadone is required.
Modes of cell demise comprise a number of processes such as
apoptosis and necrosis and intermediate options [18]. Calcium (Ca2+)
and reactive oxygen species (ROS) have been proposed as second
messengers involved in the initial steps of cell death. One of the earliest
commitment steps towards cytotoxicity is failure of cytoplasmic Ca2+
homeostasis, also known as delayed Ca2+ deregulation (DCD). Once
DCD is initiated, the process of cell death is irreversible [19–21].
Qualitative, quantitative, and functional changes ofmitochondria have
been observed, whichmay cause or strengthen degenerative diseases.
Mitochondria-directed cell death stimuli induce a variety of cellular
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mitochondrial outer-membrane permeability (MOMP). MOMP will
decrease themitochondrialmembrane potential (ΔΨ) and lead to ATP
depletion. Two different routes have been proposed as being mainly
responsible for MOMP. First, the formation of mitochondrial perme-
ability transition pores (MPTP), and second, the translocation of pro-
apoptotic Bcl-2 family proteins, such as Bax, from the cytosol to the
mitochondrial outer membrane [22]. MOMP results in the release of
apoptogenic molecules, including cytochrome c. These molecules
contribute to the formation of the apoptosome, a multimolecular
complex that triggers caspase activation. Apoptosome formation is an
essential event for cell dismantling through the apoptotic pathway
[23]. Since the apoptotic death signalling pathway contains several
ATP-dependent steps, the route leading to cell death, apoptosis or
necrosis, is determined by the intracellular levels of ATP [24].
The present study was undertaken to characterize the cytotoxic
effects of methadone on human SH-SY5Y cells. Our results suggest
that methadone induces necrotic-like cell death, since it uncouples
mitochondria causing depletion of cellular ATP levels. This, in turn,
could be also responsible for caspase-independent cell death, even
though we observed mitochondrial cytochrome c release, DCD and
calpain-protease activation.
1. Materials and methods
1.1. Cell culture and drug treatment procedures
SH-SY5Y cultures were grown as previously described [25] (in
Dulbecco's modiﬁed Eagle's medium (DMEM) supplemented with
2 mM L-glutamine, penicillin (20 units/mL), streptomycin (5 μg/mL),
and 15% (v/v) fetal bovine serum (Gibco, Gaithersburg, MD). Cells
were grown in a humidiﬁed cell incubator at 37 °C under a 5% CO2
atmosphere. For GFP-Bax translocation and viability experiments,
cells were spotted on μ-Dish 35 mm High IbiTreat (ibidi GmbH,
Martinsried, München, Germany) at 2.9×105 cells/cm2 and allowed
to attach overnight. Immediately before methadone addition, dilu-
tions of methadone were made and added to fresh cell culture
medium. MEF p53−/− cells, a gift from Dr M. Serrano (CNIO, Spain)
and SH-SY5Y overexpressing Bcl-XL (SH-SY5Y-Bcl-XL) from Dr. J.X.
Comella (UAB, Spain), were grown in DMEM supplemented with
2 mM L-glutamine, penicillin (20 units/mL), streptomycin (5 μg/mL),
and 15% (v/v) fetal bovine serum.
1.2. Cell viability
For viability experiments, cells were plated at a density of 4×104
cells/cm2 and allowed to attach overnight. Cell viability after
methadone additions was assessed by measurement of lactate
dehydrogenase activity according to the protocol provided by the
manufacturer (Promega). Brieﬂy, the reaction mixture was added to
conditioned media and removed from 24-well plate after centrifuga-
tion at 250g for 10 min. Absorbance of samples at 490 nm was
measured in a microplate reader (BioRad, Hercules, CA) after 30 min
of incubation at room temperature.
1.3. Transfections
Cells were spotted on μ-Dish 35 mm High IbiTreat 24 h before
transfection at a density of 5.3×104 cells/cm2. Cells were transfected
with the plasmid GFP-Bax (gift from Prof. Prehn, Dublin, UK)[25].
Transfection was achieved using Lipofectamine reagent (Invitrogen,
Carlsbad, CA), according to the manufacturer's protocol. After 4 h of
incubation the transfection mixture was removed and replaced with
fresh complete medium. At 12 h after transfection, the percentage of
cells positive for GFP expression was N70% in each experiment.1.4. Chromatin state
SH-SY5Y cells were spotted on μ-Dish 35 mm High IbiTreat. After
treatment, the glass slides were rinsed three times with PBS and
then incubated with 0.5 μg/ml of Hoechst 33342 (Molecular Probes,
Inc., Eugene, OR) for 5 min at room temperature. After two rinses
with PBS, chromatin staining was analyzed using a ﬂuorescent
microscope.
1.5. Caspase activity
After methadone addition, cells were collected in a buffer with
the following composition: 25 mM Hepes; 5 mM EDTA; 1 mM EGTA;
5 mMMgCl2; 5 mM DTT; 1 mM PMSF and 10 μg/ml each of pepstatin
and leupeptin; pH 7.5. The cellular material was left for 20 min on ice
and then sonicated. The lysate was centrifuged for 20 min at 10,000g
and the supernatant (30 μg protein) was incubated at 37 °C with the
ﬂuorogenic substrate DEVD-AFC (15 μM in DMSO, Calbiochem System
Products) in a buffer containing 25 mM HEPES (pH 7.5), 10% sucrose,
0.1 CHAPS and 10 mM DTT [26]. Substrate cleavage emitted a
ﬂuorescent signal that was quantiﬁed in a ﬂuorometer (lumines-
cence-spectrophotometer LS50B, Perkin Elmer, Buckinghamshire, UK)
(excitation 400 nm, emission 505 nm). Enzymatic activity is
expressed as arbitrary ﬂuorescent units (A.F.U).
1.6. Mitochondrial cytochrome c release
Methadone-treated and control cells were washed once with PBS
and collected by centrifugation (2000g; 5 min). Cell pellets were
resuspended in 200 μl of extraction buffer containing: 250 mM
sucrose, 50 mM Tris–HCl, 1 mM EGTA, 1 mM EDTA, 1 mM DTT,
0.1 mM PMSF, pH 7.4; homogenized in a Teﬂon-glass homogenizer
(5 strokes) and, after 15 min on ice, centrifuged (15,000g; 15 min).
The supernatants (cytosolic fractions) and the pellet (mitochondrial
fraction) were separated and analyzed by gel electrophoresis and
immunoblotting using anti-cytochrome c (1:1000 dilution of rabbit
polyclonal IgG, Santa Cruz Biotechnology Inc. CA) [25].
1.7. Cellular ATP concentration
ATP assays were performed using a Sigma luciferin-luciferase
assay kit. Controls and methadone-treated cells were resuspended in
1 mL H2O to disrupt the cell membrane and to quantify the cytosolic
ATP. A 10-μl sample was added to 10-μl luciferin–luciferase reaction
mix, and immediately the luminescence was read using a lumin-
ometer. All values were divided by the protein content (Micro BCA
Protein Reagent Kit, Pierce, Rockford, IL), for normalization. Each
sample was read three times and the experiment was performed in
triplicate.
1.8. Mitochondrial isolation
Rat liver mitochondria were isolated in MSH/EDTA and MSH
media containing 210 mM mannitol, 70 mM sucrose, 5 mM Hepes,
with or without 1 mM EDTA, pH 7.4, by centrifugal differentiation as
described [27]. Mitochondrial protein concentration was measured
using the Micro BCA Protein Reagent Kit. The mitochondrial suspen-
sions were kept on ice and immediately used for measurements of
oxygen consumption and H2O2 production.
1.9. Mitochondrial permeability transition pore activity
Mitochondrial permeability transition pore (MPTP) opening was
assayed spectrophotometrically as previously described [28]. In brief,
mitochondria were suspended to reach a protein concentration of
1 mg ml−1 in 200 μl of solution containing 125 mM KCl, 20 mM
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5 mM glutamate with the pH adjusted to 7.08 with KOH. After
addition of different compounds, changes in absorbance at 540 nm
(A540), indicating mitochondrial swelling due to MPTP opening, were
determined using a microplate reader (BioRad, Hercules, CA). Initial
A540 values were ~0.8, and minor differences in the loading of the
wells were accounted for by representing the data as the fraction of
the initial absorbance. Methadone (0.25 or 0.5 mM) was added at the
start of the OD measurements which were carried out for 60 min.
1.10. Mitochondrial H2O2 generation
The rate of mitochondrial H2O2 production was assayed by
measuring the increase in ﬂuorescence (excitation at 312 nm,
emission at 420 nm) due to oxidation of homovanillic acid by H2O2
in the presence of horseradish peroxidase [29]. Reaction conditions
were 0.25 mg/ml of mitochondrial protein, 6 U/ml horseradish
peroxidase, 0.1 mM homovanillic acid, 50 U/ml superoxide dismutase
in the incubation buffer (145 mM KCl, 30 mM Hepes, 5 mM KH2PO4,
3 mM MgCl2, 0.1 mM EGTA, 0.1% BSA, pH 7.4) at 37 °C. Methadone
was added to mitochondria just before starting the reaction. To start
the reaction 2.5 mM glutamate/2.5 mM malate or 5 mM succinate
were added as substrates. In some experiments rotenone (2 μM) was
included in the reactionmixture to assay maximum rates of complex I
and basal complex III H2O2 generation. Duplicate samples were
incubated for 15 min at 37 °C. The reactions were stopped by
transferring the samples to an ice-cold bath and adding 0.5 ml of
stop solution (2.0 M glycine, 2.2 M NaOH, 50 mM EDTA, pH 12).
Fluorescence was read in a LS50B Perkin-Elmer ﬂuorometer. Known
amounts of H2O2 generated in parallel by glucose oxidase with
glucose as substrate, were used as standards. Since the superoxide
dismutase added in excess converts all O2− excreted by mitochondria
(if any) to H2O2, the measurements represent the total (O2−+H2O2)
rate of mitROS production.
1.11. Mitochondrial oxygen uptake
The rate of oxygen consumption of isolated liver mitochondria was
measured at 37 °C in a water-thermostatized incubation chamber
with a computer-controlled Clark-type O2 electrode (Oxygraph,
Hansatech, UK) in 0.5 ml incubation buffer (145 mM KCl, 30 mM
Hepes, 5 mM KH2PO4, 3 mM MgCl2, 0.1 mM EGTA, 0.1% defatted BSA,
pH 7.4). The substrates used were complex I- (2.5 mM glutamate/
2.5 mM malate) or complex II-linked (5 mM succinate+2 μM
rotenone). The assays were performed in the absence (state 4-resting
state) or in the presence (state 3-phosphorylating state) of 0.5 mM
ADP. The total amount of oxygen consumed during state 3 respiration
was used for calculating the ADP/O ratio. Different amounts of
methadone, in a ﬁnal volume of 0.2 mL, were added as marked by an
arrow in the graphic. Final concentrations in each condition are
indicated. Methadone (0.5 mM, if not indicated otherwise) was added
during oxygen uptake.
1.12. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
reduction
Reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide (MTT) to a blue-colored formazan dye was used to
assess the activity of the electron ﬂow along the respiratory chain
[30]. Samples of mitochondria (0.1 mg protein) were incubated for
5 min in incubation buffer supplemented with 2.5 mM glutamate/
2.5 mM malate in the presence of 0.5 mM methadone or 2 μM
rotenone. Then, tubes were warmed to 25 °C in the presence of MTT
(0.1 mg/ml) and incubated for another 5 min. Samples were
centrifuged and the pellets were resuspended in 1 ml ethanol.
Reduction of MTT was measured at 595 nm.1.13. Integrity of the mitochondrial outer membrane
Determination of the mitochondrial outer membrane integrity was
based on the permeability of the membrane to the exogenous
cytochrome c [31]. Rat liver mitochondria were treated with antimycin
A (5 μg/mg) to block the respiratory chain, separated from the
cytochrome c oxidase segment. Then, 8 mM ascorbate, cytochrome
c (0.06%) and N,N,N',N'-tetramethyl-1,4-phenylenediamine (TMPD) (in
portions of 0.5 mM),were added to get the saturation effect.Methadone
(0.5 mM) was added 45 sec prior to antimycin A addition. Respiration
rates were calculated using the formula:
cytC asc
TMPD asc × 100% = I %ð Þ
where I indicates the level of rupture of the outer membrane.
1.14. Conductance measurements in the planar bilayer lipid membrane
(BLM)
Membranes were formed from soybean asolectin, suspended at a
concentration of 25 mg/mL in n-decane, across a circular hole (aperture
diameter about 250 μm) in the thin wall of a Delrin chamber (Warner
Instruments) separating two compartments (cis–trans). The chamber
was connected to recording equipment through a matched pair of Ag-
AgCl electrodes. Methadone was added in small aliquots to the cis
compartment, where also the voltage was held. Both compartments
were ﬁlled with unbuffered 1 M KCl, pH 7.0 in the presence of a voltage
of 10 mV, or with 20 mM Tris buffer of pH, 6.8 in the cis compartment
and pH 8.8 in the trans compartment (pH gradient) or with different
concentrations of CaCl2 (pH 7.4), 60 mM in the cis compartment and
20 mM in the trans compartment (Ca2+ gradient). Signals were
ampliﬁed with a BLM-120 bilayer ampliﬁer (Bio-LOGIC Science
Instruments) and computer software was used for data collection. The
amount of recorded events for a given set of conditions was 20.
1.15. Western blot analysis
SH-SY5Y cell cultures were washed twice with ice-cold PBS and then
collected bymechanical scraping in PBS. The suspensionwas centrifuged
at 16,000g for5 min, and thepelletwas resuspended in samplebuffer. The
protein concentration in each sample was quantiﬁed (BCA), and equal
amounts of protein (30 μg) were loaded on 10% SDS-PAGE gels. After
electrophoresis, proteins were transferred to Immobilon PVDF mem-
branes. Non-speciﬁc protein binding was blocked with Blotto [4% w/v
non-fat driedmilk, 4% bovine serum albumin (Sigma) and 0.1% Tween 20
(Sigma)] in PBS for 1 h. Themembraneswere incubated overnight at 4 °C
with anti-p53 [1:1000 dilution of anti-mousemonoclonal (Pab240) sc-99
Santa Cruz], anti-α-fodrin 1:1000 dilution (MAB1622; Chemicon, Milli-
pore Corporation, Billerica, MA) or anti-alpha-tubulin (1:40.000, from
Sigma (St. Louis, MO). After washing with Blotto, the membranes were
incubated for 1 h with a secondary antibody (1:5000 dilution of
peroxidase-labeled anti-mouse, Promega, Madison, WI) in Blotto. The
signal was detected using enhanced chemiluminescence detection
(Amersham). Immunoblots were developed by exposure to x-ray ﬁlms
(Eastman-Kodak, Rochester, NY). Band intensities were estimated
densitometrically on a GS-800 calibrated densitometer (Biorad One).
1.16. Intracellular calcium concentration
Changes in [Ca2+]i in SH-SY5Y cells attached to glass coverslips were
measured ﬂuorimetrically. Cells were incubated for 45 min at 37 °C in
Krebs–Hepes solution (144 mM NaCl, 2 mM CaCl2, 5.9 mM KCl, 1.2 mM
MgCl2, 11 mM glucose, 10 mM Hepes/NaOH; pH 7.4) containing 7.0 μM
fura-2 AM and 16 μM pluronic F-127 (Invitrogen). Loading with
ﬂuorescent dye was stopped by washing the cells with Krebs–Hepes
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microscope (Nikon Eclipse TE2000-S). Fura-2 was alternatingly excited
at 340 and 380 nm using a monochromator; emitted light was
transmitted through a 505-nm dichroic mirror and 510 nm emission
ﬁlter before being detected by a CCD camera. Data were analysed using
the Metaﬂuor vs. 2.2 program (Universal Imaging, Downingtown).Fig. 1. Methadone induces cell death in SH-SY5Y cell cultures. (A) Cell viability was measur
represent mean±S.E.M. from at least three independent cultures. *pb0.001. (B) Time cour
represents the mean±SEM of 5 different cultures. *pb0.001. (C–F) Equal amounts of subco
(0.5 mM) for 24 h. (C and D) Phase-contrast microscopy and (E and F) cells stained w
(magniﬁcation ×63).1.17. Statistics
When only two means were compared, Student's t-test was used.
For more than two groups of data, statistical signiﬁcance was assessed
by analysis of variance (ANOVA) and by comparison using Turkey's
test. Differences were considered signiﬁcant at Pb0.05.ed 24 h after methadone addition using LDH release as an indicator of cell death. Data
se of cell viability upon 0.5 mM methadone addition to SH-SY5Y cell cultures. Each bar
nﬂuent SH-SY5Y cells were incubated with (D and F) or without (C and E) methadone
ith Hoechst 33348, examined under an inverted microscope with ultraviolet light
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2.1. Methadone induces necrotic-like cell death in SH-SY5Y cell cultures
Methadone is toxic to different lines cell cultures. In the ﬁrst set of
experiments, we tested the sensitivity of the human neuroblastoma
cell line SH-SY5Y to methadone. As shown in Fig. 1A, methadone
triggered a concentration- and time-dependent increase in cell death
of SH-SY5Y, ranging from 15% to 70% killed cells at a 0.25- to 1.00-mM
concentration at 24 h after continuous exposure (Fig. 1A). Methadone
treatment at 0.5 mM led to ~40% cell death after 24 h and was used in
subsequent experiments. Next, a time-dependent analysis wasFig. 2.Methadone induces Ca2+ dyshomeostasis. (A–C) [Ca2+]i in SH-SY5Y cells was measur
cells that exhibit types 1–4 in [Ca2+]i over time. Data represent those of control (305 cells)
Methadone did not induce H2O2 production in mitochondria isolated from liver. Histogram
complex III (C-III) in the presence ofmethadone. Data shown aremean±SEM obtained from
not prevent methadone-induced cell death. Coenzyme Q (50 μM), MnTBAP (10 μM), Trolo
methadone. Cell viability was determined 24 h after methadone addition. Values representperformed. During the initial 9 h of exposure, minimal changes in
viability of the cultures were observed, however signiﬁcant cell death
wasdetected at later timepoints (Fig. 1B). Phase-contrastmicroscopyof
SH-SY5Y cells showed a ﬂattened morphology and extended neuritis
under control conditions (Fig. 1C), whereas the addition of 0.5 mM
methadone induced neurite retraction, absence of cytoplasmic exten-
sions and cell rounding (Fig. 1D). Using dye Hoechst 33348 the
chromatin state in cells challenged with methadone was analyzed.
Cellswith fragmented chromatinswere not overrepresented in cultures
challenged for 24 hwithmethadone as compared to the control (Fig. 1E
and F). The absence of this hallmark of apoptosis suggests that rather
than apoptosis a necrotic-like cell death process might be involved.ed for 30 min. (B) Representative responses for four different cell types. (C) Fractions of
or with methadone (258 cells) studied in 18 independent experiments. *pb0.001. (D)
illustrates the rates of H2O2 production of complex I (C-I), complex I-III (C-I–III) and
four independent mitochondrial preparations. (E) Treatment with antioxidant drugs did
x (0.75 mM), TEMPOL (0.2 μM) or ascorbic acid (500 μM) were added 30 min prior to
the mean±SEM of 5 experiments.
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transduced through opiate receptors, the effect of naloxone, an opiate
receptor antagonist, on methadone-induced SH-SY5Y cell death was
determined. Naloxone (10 μM) did not prevent methadone-induced
cytotoxic effects (0.5 mM methadone 46.26±5.22 %; methadone+
naloxone 41.36±6.36 % cell viability; n=5).
2.2. Methadone induces deregulation of Ca2+ but not ROS homeostasis
In the next set of experiments, the possible participation of second
messengers such as Ca2+ and ROS in methadone-induced cell death
was analyzed. SH-SY5Y cells were loaded with fura2/AM to monitor
changes in intracellular Ca2+ concentrations ([Ca2+]i.). Fig. 2A shows
images corresponding to [Ca2+]i during perfusion with and without
methadone (0.5 mM) at different time points. Four different cell
populations (types 1–4) can be distinguished by their response toFig. 3.Methadone induces cytochrome c release, but does not activate the caspase-mediated
the mitochondria to the cytosol. Cytosolic (CF) and mitochondrial (MF) fractions from SH-SY
for cytochrome c by immunoblotting. Shown is a representative experiment that was repe
densitometric analysis. (B) Methadone fails to induce DVED-like caspase activity in SH-SY5Y
DVED-like caspase activity. Data represent mean±SEM of three experiments measured in
cultures were incubated with 100 μM Ac-ZVAD-FMK from 30 min prior the addition of met
represent mean±SEM of three independent experiments measured in duplicate. (D) Meth
Immunoblot of total cellular extracts from SH-SY5Y cultures challenged with methadone. Ex
control of caspase activation. (E) Methadone induces ATP depletion. Cell cultures were chal
expressed relative to control cultures. Data shown are mean±SEM obtained from three indmethadone (Fig. 2B). About 42% of the cells showed no rise in [Ca2+]i
during the entire [Ca2+]i measurement period (Type 1; Fig. 2B).
Among the remaining cells, we observed cells that were unable to
regulate [Ca2+]i homeostasis shortly upon the addition of methadone
(type 2, 22% of the cells) and cells where [Ca2+]i deregulation takes
place with a delay few minutes (type 3, 8.1%). The remaining 26% of
the cells were able to control [Ca2+]i after an initial increase (type 4,
Fig. 2C). In the same period, cells not exposed to methadone showed
no increase in [Ca2+]i. This intracellular response required the
presence of extracellular calcium, because when Ca2+ was withdrawn
from the extracellular medium, methadone failed to increase
intracellular calcium levels (n=48 cells).
To determine if methadone was modifying mitochondrial ROS
(mitROS) homeostasis, the rate of mitochondrial H2O2 production in
isolated mitochondria was measured as the increase in ﬂuorescence
due to oxidation of homovanillic acid by H2O2. Methadone failed topathway. (A) Methadone induces a time-dependent translocation of cytochrome c from
5Y cells challenged with methadone were collected at the indicated times and assayed
ated three times with similar results. Histograms represent the relative values of the
cells. As a positive control, staurosporine (100 nM, 24 h) treatment markedly increased
triplicate. (C) Inhibition of caspase did not block methadone-induced cell death. Cell
hadone until the end of the experiment. Cell viability was determined after 24 h. Data
adone induced calpain but not caspase signature spectrin breakdown products (SBDP).
tracts from cells challenged with staurosporine (100 nM, 24 h) were used as a positive
lenged with methadone and 24 h later the ATP levels were determined. ATP levels are
ependent cultures. *Pb0.05; ***Pb0.001.
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Consistent with this absence of mitROS deregulation by methadone,
30 min pre-treatment with different ROS scavenger drugs such as
Coenzyme Q (50 μM), MnTBAP (10 μM), Trolox (0.75 mM), TEMPOL
(0.2 μM) or ascorbic acid (500 μM) did not provide cytoprotection to
SH-SY5Y cells against methadone-induced toxicity (Fig. 2E).
2.3. Interaction of methadone with the mitochondrial-based apoptotic
pathway
The mitochondrion has been proposed to be the headquarters for
cell death processes [22]. When the intrinsic or mitochondrial-based
cell death pathway is engaged, pro-apoptotic factors such as
cytochrome c are released from mitochondria with subsequent
activation of caspase-3. Release of cytochrome c to the cytoplasm
was detected in extracts from SH-SY5Y cells following methadoneFig. 4. Effect of methadone on the mitochondrial respiratory chain. (A–B) Inﬂuence of 0.5 m
FCCP in the presence of complex I (2.5 mM glutamate/2.5 mMmalate) or complex II (5 mM s
nmol oxygen/mg protein/min at 37 °C. Traces shown are the mean obtained from 7 mitoc
chain. Rotenone, which blocks the transfer of electrons from FeS N-2 centers to ubiquinone
independent mitochondria preparations.exposure (Fig. 3A). Cytosolic levels of cytochrome c began to increase
at 3 to 6 h post-treatment. However, no activation of caspase-3
enzymatic activity was found in cellular extracts using DEVD-AFC as a
ﬂuororimetric substrate (Fig. 3B). Furthermore, Ac-ZVAD-FMK, a
wide-spectrum caspase inhibitor [32], did not abrogate methadone-
induced cell death (Fig. 3C). Finally, the activity of caspase-3 was
monitored as proteolysis of the cytoskeletal protein alpha-spectrin
into spectrin breakdown products (SBDP). Extracts from methadone
treated cells showed large increases of 145 kDa calpain-mediated
SBDP (up to 3-fold) by 6 h after addition.
One possible explanation for the lack of caspase-3 activation after
cytochrome c release found in our experiments might be that ATP was
depleted due to methadone treatment. To address this issue, ATP
levels in cells challenged for 24 h with methadone were measured by
the luciferase method. As shown in Fig. 3E, methadone caused
depletion of ATP levels in a concentration-dependent way.M methadone on uncoupled state respiration. Uncoupled state was triggered by 1 μM
uccinate) dependent respiration. The numbers on the traces refer to respiration rates in
hondria preparations. (C) Effect of methadone on electron ﬂow within the respiratory
, was used as a negative control. Data shown are the mean±SEM obtained from three
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To check if the ATP depletion results from inhibition of the
mitochondrial respiratory chain, the effect of methadone on un-
coupled state respiration, triggered in isolated mitochondria by FCCP
in the presence of complex I or complex II dependent respiration was
measured. For this purpose, glutamate/malate and succinate were
used as respiratory substrates. Since uncoupled state is the state of
maximum capacity of the respiratory chain, the inhibitory effect of
methadone could be easily monitored. Independent of the respiratory
substrate used, the rate of oxygen uptake in the presence of FCCP
relative to the rate of oxygen uptake in the absence of the uncoupler
(the FCCP/substrate ratio) did not signiﬁcantly change in the presenceFig. 5. Effect of methadone on mitochondrial respiration. (A–B) Titrations of state 4 and sta
malate (A) or 5 mM succinate (in the presence of 2 μM rotenone) (B). The respiration rate o
methadone on state 4 and state 3 respiration obtained for glutamate/malate as a respiratory
mean of six independent mitochondria preparations. Numbers on the traces refer to respir
calculated values of the RCR (open squares) and ADP/O (solid circles) in the presence o
conductivity induced in bilayer lipid membrane by 0.5 mMmethadone in the presence of 1 M
records obtained for a given set of conditions; 1. control, 2. ΔpH, 3. 1 M KCl, 4. ΔCa2+.of methadone. Thus, the effect of methadone onmitochondriawas not
due to inhibition of any of the respiratory chain complexes.
Furthermore, in the presence of the synthetic electron acceptor MTT
inhibition of electron transfer within the respiratory chain was not
observed (Fig. 4C).
To further study changes of mitochondrial activity imposed by
methadone, the effect on mitochondrial oxygen uptake coupling to
ATP synthesis was measured. Using glutamate/malate and succinate
as respiratory substrates, methadone increased the rate of oxygen
uptake in state 4 (resting state) in a concentration-dependent
manner, and had no effect on state 3 (phosphorylating state, coupled
to ATP synthesis) (Fig. 5A–B). The traces obtained for glutamate/
malate in the presence of 0.125 and 0.25 mM methadone in ate 3 respiration with methadone. State 4 was supported by 2.5 mM glutamate/2.5 mM
f state 3 was measured in the presence of 500 μM ADP. (C) Traces showing the effect of
substrate in the presence of 0.125 mM and 0.25 mMmethadone. Traces shown are the
ation rates in nmol oxygen/mg protein/min at 37 °C. (D–E) Methadone effect on the
f 2.5 mM glutamate/malate (D) or 5 mM succinate (E). *Pb0.05; ***Pb0.001. (F) Ion
KCl, proton gradient or Ca2+ gradient. The presented events are representative for 20
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concentration-dependent manner, increased the respiratory rate of
state 4 but hardly modiﬁed the respiratory rate of state 3. As a con-
sequence, the respiratory control ratio (RCR) values calculated for
both glutamate/malate and succinate were clearly lowered in the
presence of methadone (Fig. 5D–E) suggesting uncoupling. Moreover,
methadone also resulted in a delay of return to the resting state 4
leading to a decrease of the ADP/O ratio (Fig. 5D–E), which supports
uncoupling. To quantify the effects of methadone on state 4
respiration supported by either glutamate/malate or succinate we
calculated the values of K0.5methadone, which represents the concentra-
tion of methadone resulting in half-maximum of its effect on state 4.
The calculated values were 0.126 mM for glutamate/malate and
0.143 mM for succinate. This small difference indicates that the
observed effect of methadone was not inﬂuenced by the applied
respiratory substrate, and probably reﬂects uncoupling which might
result from a possible interaction with phospholipid membranes [33].
To check this possibility a set of experiments using the planar bilayer
lipid membrane (BLM) model were performed. As shown in Fig. 5F, in
the presence of a proton gradient or KCl methadone induced ion
permeability in planar phospholipid membranes indicating that
methadone has ionophoric, including protonophoric, properties.
However, in the presence of a Ca2+ gradient, the permeability is not
triggered, which suggests ion selectivity of the methadone effect.
2.5. Bax redistribution, but not MPTP, participates in mitochondrial outer
membrane permeabilization changes.
Cytochrome c is released from mitochondria as a result of changes
in permeabilization of the outer mitochondrial membrane, through
different mechanisms such as the formation of MPTP or the
translocation of Bax to the mitochondrion. Changes in the absorbanceFig. 6. Methadone induces MOPM trough Bax translocation. (A) Methadone does not induc
Mitochondrial swelling was measured by changes in absorbance at 540 nm. Ca2+ was used a
performed in triplicate. Similar data were obtained with seven different mitochondrial prepa
the permeability of the membrane to the exogenous cytochrome c. 0.5 mM methadone w
experiments, each performed in triplicate. (D–E) SH-SY5Y cells were transfected with GFP–B
was added. After 12 h of exposure to methadone, the cells were ﬁxed and confocal imag
methadone treatment. Values are the mean±SEM of four experiments, each performed inof a mitochondrial suspension at 540 nm can be used to monitor
mitochondrial swelling though the activity of MPTP.Methadone failed
to induce mitochondrial swelling at any of the concentrations tested
(Fig. 6B). Addition of 75 μM CaCl2 was used as control trigger of
mitochondrial swelling. To analyse whether methadone pre-disposes
mitochondria to Ca-induced swelling, isolated mitochondria were
pre-incubated wit methadone for 30 min before Ca2+ addition. Under
these conditions methadone did not affect Ca-induced swelling (data
not show). In addition, the integrity of the mitochondrial outer
membrane in isolated mitochondria preparations was assayed by
determination of the membrane permeability to exogenous cyto-
chrome c. The value of the integrity index (I), which indicates the
fraction of mitochondria with the outer membrane disrupted, was
15.4±1.56% in the absence of methadone and 14.7±2.89 (PN0.05) in
the presence of methadone (Fig. 6B). Moreover, the effects of
methadone on mitoplast oxygen uptake were similar to those
observed for mitochondria, indicating no effect on the mitochondrial
outer membrane (data not shown). We therefore conclude that
methadone did not affect the outer membrane.
To determine whether Bax protein was translocated from the
cytoplasm to themitochondria aftermethadone addition, we transient-
ly overexpressed GFP-Bax in SH-SY5Y cells and visualized the
ﬂuorescence pattern after drug treatment [25]. The GFP-Bax ﬂuores-
cence changed from a diffuse, cytosolic pattern to a punctuated,
mitochondrial pattern upon translocation (Fig. 6C, lower panel).
Quantiﬁcation indicated methadone signiﬁcantly induced Bax translo-
cation to the mitochondria after 12 h of treatment (Fig. 6D).
2.6. Cellular pathways involved in methadone-induced cell death
The induction of certain genes such as p53 has been shown to be
a requirement in cell death induced after DNA damage [25,34].e MPTP formation. Methadone was added (0.25 and 0.5 mM) to isolated mitochondria.
s a positive control for mitochondrial swelling. Values are the mean from an experiment
rations. (B–C)Methadone does not disrupt the outer mitochondrial membrane based on
as added. The values of the integrity index (I) are the mean±SEM of at least four
ax, incubated for 24 h to allow for sufﬁcient GFP-Bax expression after which methadone
es were captured. (F) Fraction of cells with punctuate Bax distribution after 12 h of
triplicate. *Pb 0.001.
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SY5Y cells was studied. Methadone did not promote the accumulation
of p53protein as compared to untreated cells at any timepoint assayed
(Fig. 7A). Furthermore, the phosphorylation levels of p-53 at serine15
also remained unchanged (Fig. 7A). As expected from these results,
methadone-induced cell death was not abrogated, either when p53
activity was inhibited with piﬁthrin-α (500 nM), or when ﬁbroblast
cultures from mice lacking p53 (MEF p53−/−) were used (Fig. 7B).
To further study the mitochondrial-based pathway, the role of the
anti-apoptotic protein Bcl-XL in SH-SY5Y cells challenged with
methadone at different time points was analyzed. As shown, the
levels of this protein remained unchanged after the addition of
methadone (Fig. 7A). Further experiments using SH-SY5Y cells
overexpressing Bcl-XL (SH-SY5Y-Bcl-XL)[35] revealed that overex-
pression of this anti-apoptotic protein did not provide any protection
against methadone-induced cell death (Fig. 7B).
3. Discussion
This study was aimed at addressing whether an overdose of
methadone is related to alterations in cell survival. We demonstrated
that high concentrations of methadone promoted death of SH-SY5Y
cells, and obtained new evidence that drug abuse may cause death of
neuronal cells resulting in irreversible neuronal damage. The
pharmacological cause of this effect seems to be related to a depletion
of cellular ATP levels by impaired functioning of mitochondria.Fig. 7. Methadone does not to activate cellular pathways. (A) Total cellular extracts from SH
points and assayed by immunoblotting. Shown is a representative experiment that was repea
the ﬁlters with p53 or anti-α-tubulin antibodies. Histograms represent the relative values fro
the overexpression of Bcl-XL (SH-SY5Y-Bcl-XL), by deﬁciency in p53 (MEF p53−/−) proteins
24 h of treatment. Values are mean±SEM of at least three independent experiments.Although our experimental observations required high concentra-
tions of methadone to have lethal effects, this study sheds new light
on the molecular mechanism underlying the gross impairments that
may leads to neuronal damage by chronic drug abuse and opioid
addition [36]. Our data also support the high morbidity and mortality
associatedwith opioid dependence. Furthermore, becausemethadone
probably also displays large interindividual variability in its pharma-
codynamics, methadone treatment must be adjusted to each patient
individually. The high concentration required to induce toxic effects is
consistent with previous reports where opioid peptides–synthetic
and natural–at a dosage of 10−6 M did not inﬂuence the growth of the
different cell lines studied [37–39]. Other compounds, such a DAMGO,
morphine and etorphine caused signiﬁcant increase in the number of
apoptotic cells [37]. Based on experiments with the antagonist
naloxone, some of those studies, in agreement with our data, reported
that methadone-toxic pathways are not mediated by μ receptors
[37,40,41].
The cellular hallmarks analysed here indicate the involvement of a
necrotic-like pathway in methadone-induced cell death: ﬁrst, in cell
cultures challenged with methadone, fragmented chromatins were
scarce and, second, methadone resulted in a dramatic depletion of
ATP. The latter can be responsible for necrotic-like cell death since
alterations in cellular energy charge play a major role in the decision
of a cell to die by apoptosis or necrosis [42]. Necrosis has been
observed in various situations indicating that it is not linked to the
toxic effect of a particular condition. In interdigital webs of Apaf-1–/–-SY5Y cells challenged with 0.5 mM methadone were collected at the indicated time-
ted three times with similar results. Protein loading amount was checked by re-blotting
m the densitometric analysis. (B) Cell death triggered bymethadone is not prevented by
or by pretreatment with piﬁthrin-α (500 nM, 30 min). Cell death was determined after
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a programmed, non-accidental manner [43].
Our data indicate that the severe methadone-induced drop in ATP
levels is not caused by inhibition of the mitochondrial respiratory
chain. Methadone did not inhibit the respiratory chain complexes and
it inﬂuenced neither the oxygen uptake in uncoupled state nor the
electron transfer from the respiratory chain to the synthetic electron
acceptor MTT. On the other hand, the results obtained indicate that
the observed ATP depletion may consequence from mitochondrial
uncoupling. Oxygen uptake measurements showed that methadone
increased the respiratory rate of resting state 4 in a concentration-
dependent manner. It did not inﬂuence the respiratory rate of
phosphorylating state 3, although it did cause a delay of return to
the resting state 4. As a consequence, methadone decreased the
respiratory control ratio (RCR) and the ADP/O ratio. The observed
uncoupling effect of methadone did not depend on the applied
respiratory substrate as the calculated values of K0.5methadone for state 4
supported by glutamate/malate and succinate were comparable.
Moreover, as shown in BLM model, the uncoupling activity of
methadone can be explained by its capability to induce conductivity
for small ion in phospholipid membranes. Methadone is a small
molecule that contains hydrophilic and hydrophobic parts. Thus,
methadone can be regarded as a small and amphipathic molecule,
which is consistent with the basic properties of compounds that act in
the mitochondria as ionophores. Moreover, it has been shown that
methadone, like other opioids (buprenorphine, codeine, dextro-
methorphan, diprenorphine, etorphine, meperidine, morphine, and
naloxone), induces membrane leakage of liposomes composed of
phospholipids, and penetrates into monolayers made of phospholi-
pids [33]. Thus, also naloxone appears to act as an ionophore, which
could in turn explain why naloxone did not prevent the methadone-
induced cytotoxic effect. It is clear that methadone does not
selectively affect only the ion permeability of the inner mitochondrial
membrane. Nevertheless, the characteristic phospholipid composi-
tions of different cell membranes as well as existing ion gradients may
contribute to the ionophoric properties of methadone. Changes in the
ion permeability of the inner mitochondrial membrane can be easily
monitored. Accordingly, FCCP is known to uncouplemitochondria due
to an increase in the permeability of the inner membrane for protons.
However, the effect of FCCPwas also observed in the BLMmodel in the
presence of a proton gradient but not in the presence of KCl (our
unpublished results). Thus, an effect of FCCP on the outer mitochon-
drial membrane cannot be excluded but is difﬁcult to measure. Thus,
the ionophoric properties of methadone might also affect the ion
permeability of other cell membranes including the plasma mem-
brane and thereby mediate processes crucial for cell survival, e.g.
membrane voltage, intracellular ion concentration, pH and cell
volume. Importantly, as shown in the BLM model, methadone is not
able to trigger Ca2+ movement across phospholipid membranes.
Therefore changes in Ca2+ homeostasis in the presence of methadone
may be caused indirectly via changes in other ion gradients imposed
by methadone.
Methadone-induced Ca2+ homeostasis deregulation was observed
in about 40 % of the cells studied. These cells may have lost their ability
to regulate intracellular Ca2+ homeostasis. If Ca2+ plays a primary role
in SH-SY5Y cell death, individual cells with higher Ca2+ levels would
be predicted to die more rapidly. In fact, SH-SY5Y cells retained
cytoplasmic Ca2+ indicators after delayed Ca2+ deregulation (DCD),
indicating that the plasma membrane remains intact for a period of
time. One could postulate that once DCD has occurred, these cells are
committed to die, as in excitotoxic or hypoxic neuronal injury, which
has been interpreted as being causes of cell death [19–21,44].
ROS have been shown to play an important role in cell death after
Ca2+ increase. Since methadone failed to induce ROS production, our
ﬁndings suggest that ROS may be the end-products of cytotoxic
processes, triggered by a transient Ca2+ increase, rather than thecause of DCD. Consistent with this is the general ineffectiveness of
antioxidants to decrease DCD in the presence of glutamate [45].
Methadone induced indirect changes in the mitochondrial outer
membrane permeability, leading to the release of cytochrome c from
mitochondria to the cytosol. Apart from uncoupling, this may add to
an impairment of ATP synthesis. This was accompanied by the
translocation of the pro-apoptotic protein Bax from the cytosol to the
mitochondria 12 h after methadone addition but not by swelling of
the organelle as a result of opening MPTP. The Bax translocation after
methadone treatment was also not accompanied by activation of
caspase-3 activity or by the abrogation of the cytotoxic effects of
methadone by the caspase inhibitor Ac-ZVAD-FMK. This is consistent
with the general idea that apoptosis is an active, energy-requiring
process, and with experiments showing that prevention of ATP
production inhibits caspase activation in some experimental models
[24,46,47]. However, caspase activity is not a requirement for cell
death. Indeed, under some circumstances MOMP leads to a complete
loss of clonogenic survival, even when executor caspases are inactive
[48–51]. Accordingly, caspase-independent necrosis might account in
part for the relatively limited extent of abnormalities seen in some
caspase-null mutantmice. The results presented here strongly suggest
the existence of a caspase-independent cascade of events leading to
necrosis, as an alternative to the more classical caspase-dependent
cascade leading to apoptosis [43]. In contrast to our results, others
have reported that methadone does induce caspase activation and
apoptosis in leukaemia cells by activating the intrinsic mitochondrial
pathway [4]. These discrepancies might be due to differences in the
cell type, experimentalmodel or perhaps the drug concentration used.
Consistent with the idea of necrotic cell death, methadone did not
increase the phosphorylation levels of p53, which is involved in cell
death processes after DNA damage [34,52]. Our observation ﬁts well
with the data from Drummer and colleagues who demonstrated that
opioids can induce apoptosis and growth inhibition in human lung
cancer cells, despite the presence of mutations in their p53 genes [53].
Furthermore, we found no involvement of anti-apoptotic proteins
such as the Bcl-2-like protein Bcl-XL, which have been proposed to be a
part of the defence mechanism against oxidative stress [35,54]. Bcl-XL
might provide a link between cell energy metabolism and apoptosis,
and was proposed to prevent apoptosis by facilitating mitochondrial
respiration in conditions of poor metabolite supply [55,56]. Although
we have shown previously that in Bcl-XL overproducing cells
cytotoxicity is largely reduced [35], these cultures were as sensitive
to methadone as wild type cells.
In conclusion, methadone, in supratherapeutic doses, induces
necrotic-like cell death in SH-SY5 cells due to its ionophoric
properties, which caused a “bioenergetic crisis” and a decrease in
the level of cellular energy. This could also explain the toxic effect of
methadone observed in different cell types including neurons, cells
lines [41], hepatocytes [57], cancer [37] and leukaemia cells [4].
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